Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii

Journal of Clinical Microbiology

Volumn 34, Issue 6, 1996, Pages 1506-1511

  Gorgievski Hrisoho, Meri ^a   Germann, Daniel ^a   Matter, Lukas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROCONVERSION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 0029941342     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.6.1506-1511.1996     Document Type: Article

References (30)

1. Ades, A. E. 1991. Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy. Epidemiol. Infect. 107:527-535.
2. Aspoeck, H., and A. Pollak. 1992. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand. J. Infect. Dis. 84(Suppl.):32-38.
3. Berrebi, A., W. E. Kobuch, M. H. Bessieres, M. C. Bloom, M. Rolland, M. F. Sarramon, C. Roques, and A. Fournié. 1994. Termination of pregnancy for maternal toxoplasmosis. Lancet 344:36-39.
4. Brooks, R. G., R. E. McCabe, and J. S. Remington. 1987. Role of serology in the diagnosis of toxoplasmic lymphadcnopathy. Rev. Infect. Dis. 9:1055-1062.
5. Couvreur, J., and G. Desmonts. 1962. Congenital and maternal toxoplasmosis: a review of 300 congenital cases. Dev. Med. Child. Neurol. 4:519-530.
6. Couvreur, J., P. Thulliez, and F. Daffos. 1991. Foetopathie toxoplasmique. Traitement in utero par l'association pyriméthamine-sulfamides. Arch. Fr. Pédiatr. 48:397-403.
7. Decoster, A., F. Darcy, A. Caron, and A. Capron. 1988. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet ii: 1104-1107.
8. Desmonts, G., and J. Couvreur. 1974. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N. Engl. J. Med. 290:1110-1116.
9. Forestier, F., F. Daffos, P. Hohlfeld, and L. Lynch. 1991. Les foetopathies infectieuses: prévention, diagnostic prénatal, attitude pratique. Presse Med. 20:1448-1454.
10. Guerina, N. G., Hsu Ho-Wen, C. Meissner, J. H. Maguire, R. Lynfield, B. Stechenberg, I. Abroms, M. S. Pasternack, R. Hoff, R. B. Eaton, and G. F. Grady. 1994. Neonatal serological screening and early treatment for congenital Toxoplasma gondii infection. N. Engl. J. Med. 330:1858-1863.
11. Hall, S. 1992. Congenital toxoplasmosis. Br. Med. J. 305:291-297.
12. Hengst, P. 1992. Screening for toxoplasmosis in pregnant women: presentation of a screening programme in the former "East Germany", and the present status in Germany. Scand. J. Infect. Dis. 84(Suppl.):38-42.
13. Henri, T., S. Jacques, and L. Rene. 1992. Twenty-two years screening for toxoplasmosis in pregnancy: Liege-Belgium. Scand. J. Infect. Dis. 84(Suppl.): 84-85.
14. Hohlfeld, P., F. Daffos, J. M. Costa, P. Thulliez, F. Forestier, and M. Vidaud. 1994. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test or amniotic fluid. N. Engl. J. Med. 331:695-699.
15. Hohlfeld, P., F. Daffos, P. Thulliez, C. Aufrant, J. Couvreur, J. MacAleese, D. Descombey, and F. Forestier. 1989. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J. Pediatr. 115:765-769.
16. Jacquier, P., P. Hohlfeld, H. Vorkauf, and P. Zuber. 1995. Epidemiologie de la toxoplasmose en Suisse: étude nationale de séroprévalence menée chez les femmes enceintes en 1990-1991. Schweiz. Mcd. Wochenschr. 125(Suppl. 65):29S-38S.
17. Joynson, D. H. 1992. Epidemiology of toxoplasmosis in the U.K. Scand. J. Infect. Dis. 84(Suppl.):65-69.
18. Lappalainen, M., P. Koskela, M. Koskiniemi, P. Ammala, V. Hiilesmaa, K. Teramo, K. O. Raivio, J. S. Remington, and K. Hedman. 1993. Toxoplasmosis acquired during pregnancy - improved serodiagnosis based on avidity of IgG. J. Infect. Dis. 167:691-697.
19. Montoya, J. G., and J. S. Remington. 1995. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin. Infect. Dis. 20:781-789.
20. Peckham, C., and S. Logan. 1993. Screening for toxoplasmosis during pregnancy. Arch. Dis. Child. 68:3-5.
21. Pinon, J. M., H. Thoannes, P. H. Pouletty, J. Poirriez, J. Damiens, and P. Pelletier. 1986. Detection of IgA specific for loxoplasmosis in serum and cerebrospinal fluid using a nonenzymatic IgA-capture assay. Diagn. Clin. Immunol. 4:223-227.
22. Pons, J. C., C. Sigrand, L. Grangeot-Keros, R. Frydman, and P. Thulliez. 1995. Congenital toxoplasmosis: mother-to-fetus transmission of pre-pregnancy infection. Presse Med. 24:179-182.
23. Raeber, P. A., K. Biedermann, M. Just, and P. Zuber. 1995. Die Präevention der kongenitalen Toxoplasmose in Europa. Schweiz. Med. Wochenschr. 125(Suppl. 65):96S-102S.
24. Remington, J. S., M. J. Miller, and I. Brownlee. 1968. IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases. J. Lab. Clin. Med. 71:855-866.
25. Roizen, N., C. N. Swisher, M. A. Stein, J. Hopkins, K. M. Boyer, E. Holfels, M. B. Mets, L. Stein, D. Patel, P. Meier, S. Withers, J. Remington, D. Mack, P. T. Heydemann, D. Patton, and R. Mcleod. 1995. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 95:11-20.
26. Stepick-Biek, P., P. Thulliez, F. G. Araujo, and J. S. Remington. 1990. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J. Infect. Dis. 162:270-273.
27. Stray-Pedersen, B., and P. Jenum. 1992. Current status of toxoplasmosis in pregnancy in Norway. Scand. J. Infect. Dis. 84(Suppl.):80-83.
28. Thalhammer, O. 1973. Prevention of congenital toxoplasmosis. Neuropaediatrie 4:233-237.
29. Thulliez, P., F. Daffos, and F. Forestier. 1992. Diagnosis of toxoplasma infection in the pregnant women and the unborn child: current problems. Scand. J. Infect. Dis. 84(Suppl.):18-22.
30. Wong, S. Y., and J. S. Remington. 1994. Toxoplasmosis in pregnancy. Clin. Infect. Dis. 18:853-862.